Shannon Smith

Title: Innovations of Shannon Smith in the Field of Ginsenosides

Introduction

Shannon Smith is an accomplished inventor based in Murfreesboro, TN (US). He has made significant contributions to the field of ginsenosides, particularly in the development of compositions that utilize ginsenoside 20(S)-Rg3. His work focuses on methods to inhibit alpha herpesvirus, which includes herpes simplex virus types 1 and 2.

Latest Patents

Shannon Smith holds one patent for his innovative work. The patent is titled "Compositions including ginsenoside 20(S)-Rg3 and methods of using ginsenoside 20(S)-Rg3 to inhibit alpha herpesvirus." This disclosure describes a composition that includes ginsenoside 20(S)-Rg3, also referred to as Rg3, and outlines methods for using this composition to treat or prevent infections caused by alpha herpesviruses. Notably, the composition is designed to be substantially free of other ginsenosides, enhancing its specificity and effectiveness.

Career Highlights

Shannon Smith is affiliated with Middle Tennessee State University, where he continues to engage in research and innovation. His work has the potential to impact the treatment of viral infections significantly.

Collaborations

Shannon collaborates with notable colleagues, including Stephen Wright and Karen Maynard, who contribute to his research endeavors. Their combined expertise enhances the quality and scope of their work in the field.

Conclusion

Shannon Smith's innovative contributions to the field of ginsenosides demonstrate the importance of research in developing effective treatments for viral infections. His patent on ginsenoside 20(S)-Rg3 showcases the potential for advancements in medical science.